Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, Medpace Holdings, Inc. reported revenue of $2.53B, up 20.0% year over year. Operating margin was 21.1% and net margin 17.8%, on a free-cash-flow margin of 26.9% with capital expenditure at 1.2% of revenue. Every figure is computed directly from MEDP's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $2.53B | 21.1% | 17.8% |
| FY2024 | $2.11B | 21.2% | 19.2% |
| FY2023 | $1.89B | 17.9% | 15.0% |
| FY2022 | $1.46B | 19.1% | 16.8% |
| FY2021 | $1.14B | 17.4% | 15.9% |
How does MEDP compare against its actual peer set?
The full CompsDesk Peer Benchmark Pack: up to 14 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, provenance for every number, board-ready PDF + CSV. One-off $249.
Related in the same sector: AACG · ABSI · ACCS · ACM · ADUS · AGL
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.